General Motors: Analysts Expect Q2 Revenues Of $30.9 Billion

General Motors (NYSE: GM) will be reporting its second quarter financial results before the market opens on August 4. Analysts have a consensus $72.68 12-month price target on the company, via a total of 22 analysts, with 8 analysts having strong buy ratings, 12 analysts having buy ratings and 2 have hold ratings. The street high comes in at a $90 price target, and the lowest target sits at $27 from Nomura.

10 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 10 analysts is $30.89 billion; this number has been revised upwards from $32.99 billion at the start of the year. The highest revenue estimate is $34.38 billion, while the lowest is $25.14 billion.

The analyst consensus for net income for the second quarter is $2.88 billion, which is up from the start of the year at $2.6 billion. The highest net income estimate is $3.79 billion, while the lowest is $813 million.

Onto EBITDA estimates, there are currently only 6 analysts who have second quarter EBITDA estimates. The mean is currently $4.23 billion, with this number having been revised upwards from $4 billion at the start of the year. The street high estimate currently sits at $5.35 billion in EBITDA and the lowest is $1.09 billion.

Analysts estimate that quarterly earnings per share will come in at $2.23, with this number being revised slightly higher from $1.73 at the start of the year. The street high is $2.54 and the lowest estimate is $2 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Cambria Gold To Spin Out Mt. Margaret Copper-Gold Project Into US-Focused Entity

Two Vessels Attacked Near Strait of Hormuz Within Hours as IRGC Escalates Maritime Campaign

Related News

BMO Upgrades Cineplex Price Target To $7.00, Rating To Market Perform

On Friday, Cineplex Inc (TSX: CGX) reported their third quarter results. Cineplex’s revenue was $61...

Monday, November 16, 2020, 03:36:00 PM

Equinox Gold: Mercedes Mine Sale Was “A Favourable Sale Price For A Non-Core Asset”

On December 17th, Equinox Gold (TSX: EQX) announced that they reached an agreement to sell...

Sunday, December 26, 2021, 02:14:00 PM

Chipotle: First Quarter Analyst Consensus Estimates

Chipotle Mexican Grill (NYSE: CMG) will be reporting their first quarter on April 21st after...

Sunday, April 18, 2021, 04:57:00 PM

Canaccord Lowers Aurora Cannabis Price Target To $5 Following Q2 Earnings

On February 10th, Aurora Cannabis (TSX: ACB) reported its fiscal second quarter 2022 results. The...

Sunday, February 13, 2022, 05:16:00 PM

Hexo: Canaccord Cuts Price Target In Half To $1.00

On December 14th, Hexo Corp (TSX: HEXO) reported its fiscal first quarter 2022 results. The...

Saturday, December 18, 2021, 01:23:00 PM